GeorgeCBobustucMD

Neurology • Austin, TX

Neurooncology

Physician

Join to view full profile

Dr. Bobustuc is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bobustuc's full profile

Already have an account?

Office
2600 E Martin Luther King Jr Blvd
Austin, TX 78702
Phone+1 512-505-5500

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 1999 - 2001
University of Texas Health Science Center at HoustonResidency, Neurology, 1998 - 1999
University of Texas Southwestern Medical CenterResidency, Neurology, 1996 - 1998
University of Texas Health Science Center at HoustonInternship, Transitional Year, 1995 - 1996
Carol Davila University of Medicine and PharmacyClass of 1991

Certifications & Licensure

CA State Medical License 2020 - 2026
IL State Medical License 2002 - 2026
TX State Medical License 1999 - 2026
FL State Medical License 2004 - 2025
WI State Medical License 2012 - 2023
OK State Medical License 1999 - 2003
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme Start of enrollment: 2018 Mar 28
Terminated
Phase 2

Publications & Presentations

PubMed

100 citations
Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alky...
Ameya Paranjpe, Ruiwen Zhang, Francis Ali-Osman, George C. Bobustuc, Kalkunte S. Srivenugopal
Carcinogenesis. 2014-03-01
37 citations
Epidemiology of male breast cancer.
Santhi D. Konduri, Maharaj Singh, George C. Bobustuc, Richard A. Rovin, Amin B. Kassam
Breast. 2020-08-22
16 citations
MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances resp...
George C. Bobustuc, Amin B. Kassam, Richard A. Rovin, Sheila Jeudy, Joshua Smith
Oncotarget. 2018-07-03